AAVantgarde announced the appointment of Dr. Jayashree Sahni, MD, FRCOphth, EMBA as their Chief Medical Officer
Company Information
Company
AAVantgarde Bio
Location
Milan, Lombardy, Italy
About
AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors
Fundz sees it the moment AAVantgarde Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.